AI Article Synopsis

  • Tuberculosis (TB) continues to be a major health issue in Korea, with a high incidence rate of 77 per 100,000, making it the only OECD country facing this challenge.
  • The Korean government has increased funding and improved patient management strategies since 2011, leading to an average annual reduction of 5.2% in TB cases from 2011 to 2016.
  • Despite progress, there are still challenges with existing tools for managing latent tuberculosis infection (LTBI), such as communication gaps and treatment side effects, emphasizing the need for better resources and methods.

Article Abstract

Tuberculosis (TB) in Korea remains a serious health problem with an estimated 77 per 100,000 incidence rate for 2016. This makes Korea as the only OECD country with high incidence of TB. The government has increased budgets and strengthened patient management policies since 2011. The management of latent tuberculosis was added to the response with strengthened and extensive contact investigations in the five-year tuberculosis control plan (2013-2017) and implementation was established in 2013. Due to these efforts Korea has achieved an average 5.2% reduction annually in tuberculosis incidence rate between 2011 and 2016. To further expedite the reduction of the TB burden the government has introduced additional measures including mandatory screening of latent tuberculosis infection for community workers in congregate settings including daycare centers for children, kindergarten, and teachers in schools and health care workers in clinics and hospitals to solve the problems identified through contact investigations in 2017. Providing high quality free diagnosis and treatment of active TB including for multidrug resistant TB combined with active contact investigations is the mainstay of the current programmatic response in Korea. However, the limitation of existing tools for LTBI pose challenge including absence of best mechanism for effective communication with professionals and the public, the need for at least 3 months of treatment and the risk of side effects. Developing effective tools will help to overcome these challenges.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6830170PMC
http://dx.doi.org/10.1016/j.jctube.2018.04.006DOI Listing

Publication Analysis

Top Keywords

contact investigations
12
incidence rate
8
latent tuberculosis
8
tuberculosis
6
korea
5
tuberculosis prevention
4
prevention care
4
care korea
4
korea evolution
4
evolution policy
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!